The genetic background of Parkinson’s disease and novel therapeutic targets-Reference-Cited by-同舟云学术

The genetic background of Parkinson’s disease and novel therapeutic targets

Published:2022-10-03 Issue:10 Volume:26 Page:827-836
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Salamon András¹,Zádori Dénes¹,Szpisjak László¹,Klivényi Péter¹,Vécsei László¹²

Affiliation:

1. Interdisciplinary Excellence Centre, Department of Neurology, Albert Szent-Györgyi Faculty of Medicine School, University of Szeged, Szeged, Hungary

2. Department of Neurology, ELKH-SZTE Neuroscience Research Group, Eötvös Loránd Research Network, University of Szeged, Szeged, Hungary

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2153037

Reference33 articles.

1. Parkinson disease

2. A Practical Approach to Early-Onset Parkinsonism

3. A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing

4. Emerging Roles of Mitochondrial Serine Protease HtrA2 in Neurodegeneration

5. Genetics of Parkinson's Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease;npj Parkinson's Disease;2023-09-12

2. Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats;International Journal of Molecular Sciences;2022-12-30